Clinical Trials Browser

Phase 2 × Not yet recruiting × belzutifan × Clear all

NCT07023432 2025-06-17

Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)

Phase 2 Not yet recruiting

Carcinoma, Renal Cell